Neuroenhancers, addiction and research ethics

Shaw, David. (2012) Neuroenhancers, addiction and research ethics. Journal of medical ethics, Vol. 38, H. 10. pp. 605-608.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6070216

Downloads: Statistics Overview


In their recent paper in this journal, Heinz and colleagues accuse proponents of cognitive enhancement of making two unjustified assumptions. The first of these is the assumption that neuroenhancing drugs will be safe; the second is that research into cognitive enhancement does not pose particular ethical problems. Heinz and colleagues argue that both these assumptions are false. Here, I argue that these assumptions are in fact correct, and that Heinz and colleagues themselves make several assumptions that undermine their argument. Neuroenhancement does raise several ethical concerns, but safety and research in this area pose no unique difficulties.
Faculties and Departments:08 Cross-disciplinary Subjects > Ethik > Institut für Bio- und Medizinethik
UniBasel Contributors:Shaw, David
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:BMJ Publishing Group
Note:Publication type according to Uni Basel Research Database: Journal article
Last Modified:26 Apr 2013 06:59
Deposited On:01 Feb 2013 08:45

Repository Staff Only: item control page